New Delhi, India

Pankaj Kumar

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Johns Hopkins University, Mavenir Systems, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pankaj Kumar. Retrieved from https://idiyas.com/inventor/pankaj-kumar-1rx4vz45

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.1

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pankaj Kumar - Innovator in Cancer Treatment

Introduction

Pankaj Kumar is a notable inventor based in New Delhi, India. He has made significant contributions to the field of cancer treatment through his innovative research and patent.

Latest Patents

Pankaj Kumar holds a patent for a method of treating or preventing cancer. The patent, titled "Methods of treating or preventing cancer with an agent that depletes Tregs and a checkpoint inhibitor," describes a process that involves administering a first agent to deplete regulatory T cells (Tregs) in a subject with cancer or at risk of developing cancer. This is followed by the administration of a second agent that acts as a checkpoint inhibitor.

Career Highlights

Pankaj Kumar is affiliated with The Johns Hopkins University, where he conducts his research. His work focuses on developing innovative methods to combat cancer, showcasing his dedication to improving patient outcomes.

Collaborations

Some of his notable coworkers include William R. Bishai and John R. Murphy, who contribute to the collaborative research efforts at The Johns Hopkins University.

Conclusion

Pankaj Kumar's innovative approach to cancer treatment through his patented methods highlights his commitment to advancing medical science. His work has the potential to significantly impact the field of oncology and improve the lives of many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…